HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carpentier, A. Articles by Lewis, G. F. Search for Related Content PubMed PubMed Citation Articles by Carpentier, A. Articles by Lewis, G. F. Social Bookmarking                What's this?

The Effect of Systemic Versus Portal Insulin Delivery in Pancreas Transplantation on Insulin Action and VLDL Metabolism

¹ Medicine
² Physiology, and
³ Surgery, and the Multiorgan Transplant Program, University of Toronto, Toronto, Ontario, Canada
⁴ Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri

Combined kidney-pancreas transplantation (KPT) with anastomosis of the pancreatic vein to the systemic circulation (KPT-S) or to the portal circulation (KPT-P) provides a human model in which the chronic effects of portal versus systemic insulin delivery on glucose and VLDL metabolism can be examined. Despite similar plasma glucose and C-peptide levels, KPT-S (n = 9) had an approximate twofold elevation of fasting and intravenous glucose–stimulated plasma insulin levels compared with both KPT-P (n = 7) and healthy control subjects (n = 15). The plasma free fatty acid (FFA) levels were elevated in both transplant groups versus control subjects, but the plasma insulin elevation necessary to lower plasma FFA by 50% was approximately two times higher in KPT-S versus KPT-P and control subjects. Endogenous glucose production was similar in KPT-S and KPT-P, despite 35% higher hepatic insulin levels in the latter, and was suppressed to a greater extent during a euglycemic-hyperinsulinemic clamp in KPT-S versus KPT-P. Total-body glucose utilization during the euglycemic-hyperinsulinemic clamp was 40% lower in KPT-S versus KPT-P, indicating peripheral tissue but not hepatic insulin resistance in KPT-S versus KPT-P. Both transplant groups had an approximate twofold elevation of triglyceride (TG)-rich lipoprotein apolipoprotein B (apoB) and lipids versus control subjects. Elevation of VLDL-apoB and VLDL-TG in both transplant groups was entirely explained by an 50% reduction in clearance of VLDL compared with healthy control subjects. In the presence of increased FFA load but in the absence of hepatic overinsulinization and marked hepatic insulin resistance, there was no elevation of VLDL secretion in KPT-S versus KPT-P and control subjects. These findings suggest that chronic systemic hyperinsulinemia and peripheral tissue insulin resistance with the consequent elevation of plasma FFA flux are insufficient per se to cause VLDL overproduction and that additional factors, such as hepatic hyperinsulinemia and/or gross insulin resistance, may be an essential prerequisite in the pathogenesis of VLDL overproduction in the common form of the insulin resistance syndrome.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				L. C. Gormsen, M. D. Jensen, O. Schmitz, N. Moller, J. S. Christiansen, and S. Nielsen Energy expenditure, insulin, and VLDL-triglyceride production in humans J. Lipid Res., October 1, 2006; 47(10): 2325 - 2332. [Abstract] [Full Text] [PDF]

				L. Duvillard, E. Florentin, S. Baillot-Rudoni, M.-L. Lalanne-Mistrich, A. Brun-Pacaud, J.-M. Petit, J.-M. Brun, P. Gambert, and B. Verges Comparison of Apolipoprotein B100 Metabolism between Continuous Subcutaneous and Intraperitoneal Insulin Therapy in Type 1 Diabetes J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5761 - 5764. [Abstract] [Full Text] [PDF]

				G. Perseghin, A. Caumo, L. P. Sereni, A. Battezzati, and L. Luzi Fasting Blood Sample-Based Assessment of Insulin Sensitivity in Kidney-Pancreas-Transplanted Patients Diabetes Care, December 1, 2002; 25(12): 2207 - 2211. [Abstract] [Full Text] [PDF]

				A. Carpentier, C. Taghibiglou, N. Leung, L. Szeto, S. C. Van Iderstine, K. D. Uffelman, R. Buckingham, K. Adeli, and G. F. Lewis Ameliorated Hepatic Insulin Resistance Is Associated with Normalization of Microsomal Triglyceride Transfer Protein Expression and Reduction in Very Low Density Lipoprotein Assembly and Secretion in the Fructose-fed Hamster J. Biol. Chem., August 2, 2002; 277(32): 28795 - 28802. [Abstract] [Full Text] [PDF]

				A. Carpentier, B. W. Patterson, N. Leung, and G. F. Lewis Sensitivity to Acute Insulin-Mediated Suppression of Plasma Free Fatty Acids Is Not a Determinant of Fasting VLDL Triglyceride Secretion in Healthy Humans Diabetes, June 1, 2002; 51(6): 1867 - 1875. [Abstract] [Full Text] [PDF]

				G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Endocr. Rev., April 1, 2002; 23(2): 201 - 229. [Abstract] [Full Text] [PDF]